Skip to content

Comparison of 3 different acupoint combinations of acupuncture effect on COPD: a multicenter randomised sham-controlled trial

Comparison of 3 different acupoint combinations of acupuncture effect on COPD: a multicenter randomised sham-controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051081
Enrollment
Unknown
Registered
2021-09-11
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

Sponsors

Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with stable COPD, with stable disease in the past 4 weeks without acute exacerbation; 2. Pulmonary function classification of the severity of airflow limitation: GOLD 1-3 3. Symptom assessment and risk of acute exacerbation: Groups A and B; 4. Aged 40 to 80 years, both male and female; 5. No history of infection or aggravation of respiratory symptoms, no drug changes within 3 months before the start of the study, and no symptoms of edema; 6. Patients who can walk independently; 7. Patients who have not undergone pulmonary rehabilitation in the past 6 months; 8. Good compliance, willing to cooperate with the research, and the patients signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Combined with severe cardiovascular and cerebrovascular, nervous system, blood system, immune system, digestive system, thyroid dysfunction, chronic liver and kidney insufficiency, malignant tumor; 2. Other concomitant active or clinically significant respiratory diseases that have a significant impact on the study: such as subjects with active pulmonary tuberculosis, bronchiectasis, pulmonary hypertension, pulmonary interstitial disease or other active pulmonary diseases; 3. Those who use long-term oxygen therapy (oxygen therapy time > 15h/d) or mechanical ventilation; 4. Those who are not satisfied with blood pressure and blood sugar control; 5. Those with a history of mental illness, mental retardation, and mobility impairment; 6. Pregnant or lactating women; 7. Those who have participated in other clinical trials within the past 6 months or at the same time.

Design outcomes

Primary

MeasureTime frame
lung function;Borg dyspnea scale;

Secondary

MeasureTime frame
COPD assessment test;6-minute walk distance;

Countries

China

Contacts

Public ContactLiang Fanrong

Chengdu University of Traditional Chinese Medicine

acuresearch@126.com+86 13608058216

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026